Multidrug efflux pumps as main players in intrinsic and acquired resistance to antimicrobials
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Waves of resistance: Staphylococcus aureus in the antibiotic era
Chambers, H. F., & DeLeo, F. R. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2200 · Cited by 2,718
Clinically Relevant Chromosomally Encoded Multidrug Resistance Efflux Pumps in Bacteria
Piddock, L. J. V. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.2.382-402.2006 · Cited by 1,231 · cited 3×
“…15 antimicrobials, only those microorganisms causing infections (and eventually 16 commensals) and those efflux pumps able to extrude antibiotics in use for treating 17 infections of host-produced antimicrobials would have clinical relevance (Li and 18 Nikaido, 2009; Nikaido, 2009; Piddock, 2006a).”
BackgroundSanglard, D., Kuchler, K., Ischer, F., Pagani, J. L., Monod, M., & Bille, J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2378 · Cited by 815 · cited 1×
“Mdr1 and Flu1 are associated to 1 fluconazole resistance in C. albicans (Calabrese et al., 2000; Sanglard et al., 1995) and 2 homologs of Mdr1 have been implicated in fluconazole resistance in Candida 3 dubliniensis (Wirsching et al., 2001) and in Candida tropicalis (Barchiesi et al., 2000); 4 Mdr3…”
BackgroundPrasad, R., De Wergifosse, P., Goffeau, A., & Balzi, E. (1995) · Current Genetics · doi:10.1007/bf00352101 · Cited by 486
Multidrug efflux pumps in Gram-negative bacteria and their role in antibiotic resistance.
Blair, J. M., Richmond, G. E., & Piddock, L. J. (2014) · Future Microbiology · doi:10.2217/fmb.14.66 · Cited by 481
Coste, A. T., Karababa, M., Ischer, F., Bille, J., & Sanglard, D. (2004) · Eukaryotic Cell · doi:10.1128/ec.3.6.1639-1652.2004 · Cited by 407
Ferrari, S., Ischer, F., Calabrese, D., Posteraro, B., Sanguinetti, M., Fadda, G., Rohde, B., Bauser, C., Bader, O., & Sanglard, D. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000268 · Cited by 295 · cited 1×
“…17 the expression of Cdr1 and Cdr2, are associated with resistance to high levels of 18 fluconazole and also with an increase in the pathogen virulence (Ferrari et al., 2009), 19 indicating that, as it happens in the case of bacterial pathogens, resistance and 20 virulence might be interlinked.”
BackgroundExperimental Induction of Fluconazole Resistance in Candida tropicalis ATCC 750
Barchiesi, F., Calabrese, D., Sanglard, D., Falconi Di Francesco, L., Caselli, F., Giannini, D., Giacometti, A., Gavaudan, S., & Scalise, G. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.6.1578-1584.2000 · Cited by 145 · cited 1×
“…et al., 2000; Sanglard et al., 1995) and 2 homologs of Mdr1 have been implicated in fluconazole resistance in Candida 3 dubliniensis (Wirsching et al., 2001) and in Candida tropicalis (Barchiesi et al., 2000); 4 Mdr3 is the most important efflux pump in A. fumigatus (Nascimento et al., 2003).”
BackgroundNiimi, K., Maki, K., Ikeda, F., Holmes, A. R., Lamping, E., Niimi, M., Monk, B. C., & Cannon, R. D. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1148-1155.2006 · Cited by 134 · cited 1×
“ABC transporters in fungi are involved in cross-12 resistance to azoles (fluconazole, itraconazole, ketoconazole, voriconazole), but it 13 seems that they do not play a relevant role in the case of resistance to echinocandins 14 (Niimi et al., 2006).”
BackgroundSiikala, E., Rautemaa, R., Richardson, M., Saxen, H., Bowyer, P., & Sanglard, D. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq354 · Cited by 66 · cited 1×
“Upregulation of these efflux pumps is achieved 12 by a TAC1 gain-of-function mutation that is important in the emergence of azole-13 resistant isolates in C. albicans (Siikala et al., 2010).”
BackgroundNeisseria gonorrhoeae modulates iron-limiting innate immune defenses in macrophages
Zughaier, S. M., Kandler, J. L., & Shafer, W. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087688 · Cited by 59
Evolutionary Dynamics of Candida albicans during In Vitro Evolution
Huang, M., McClellan, M., Berman, J., & Kao, K. C. (2011) · Eukaryotic Cell · doi:10.1128/ec.05168-11 · Cited by 34 · cited 1×
“Indeed, 21 although different groups have studied this potential relationship by using azole 22 Page 35 of 77 Ac ce pt ed M an us cr ip t 35 resistant strains a clear correlation between resistance and in vitro fitness of C. 1 albicans has not been observed (Huang et al., 2011).”
Background
Cited by
Bacterial Multidrug Efflux Pumps at the Frontline of Antimicrobial Resistance: An Overview
Huang, L., Wu, C., Gao, H., Xu, C., Dai, M., Huang, L., Hao, H., Wang, X., & Cheng, G. (2022) · Antibiotics · doi:10.3390/antibiotics11040520 · Cited by 284
Osińska, A., Korzeniewska, E., Harnisz, M., Felis, E., Bajkacz, S., Jachimowicz, P., Niestępski, S., & Konopka, I. (2020) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2019.121221 · Cited by 275
Zhang, Y., Li, C., Xia, C., Wah To, K. K., Guo, Z., Ren, C., Wen, L., Wang, F., Fu, L., & Liao, N. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00955-8 · Cited by 33
“localization of ABCB1 in MDR cells The reversal of MDR in ABCB1-overexpressing cells may be mediated by downregulation of the ABCB1 transporter protein or inhibition of its drug efflux activity [40].”
Background
Metadata
- Authors
- Hernando-Amado, S., Blanco, P., Alcalde-Rico, M., Corona, F., Reales-Calderón, J. A., Sánchez, M. B., & Martínez, J. L.
- Venue
- Drug Resistance Updates
- Publisher
- Elsevier BV
- Published
- 2016-09
- Volume
- 28
- Pages
- 13-27
- ISSN
- 1368-7646 (ISSN-L)
- OpenAlex
- W2474075311
- Cited by
- 212
- References
- 12
- FWCI
- 7.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.